Filing Details

Accession Number:
0001461959-17-000003
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2017-03-30 15:36:17
Reporting Period:
2017-02-09
Filing Date:
2017-03-30
Accepted Time:
2017-03-30 15:36:17
Original Submission Date:
2017-03-30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1596062 Q Biomed Inc. QBIO () 4/A
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1461959 S William Rosenstadt Ortoli Rosenstadt Llp
501 Madison Avenue, 14Th Floor
New York NY 10022
General Counsel Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-02-09 3,800 $4.40 1,036,200 No 4 S Direct
Common Stock Disposition 2017-02-10 5,000 $4.38 1,031,200 No 4 S Direct
Common Stock Disposition 2017-02-14 4,651 $3.27 1,026,549 No 4 S Direct
Common Stock Disposition 2017-02-16 1,000 $4.00 1,025,549 No 4 S Direct
Common Stock Disposition 2017-02-17 1,800 $3.86 1,023,749 No 4 S Direct
Common Stock Disposition 2017-02-22 5,000 $3.37 1,018,749 No 4 S Direct
Common Stock Disposition 2017-03-07 900 $3.73 1,017,849 No 4 S Direct
Common Stock Disposition 2017-03-09 3,800 $3.56 1,014,049 No 4 S Direct
Common Stock Disposition 2017-03-15 1,200 $3.25 1,012,849 No 4 S Direct
Common Stock Disposition 2017-03-16 100 $2.90 1,012,749 No 4 S Direct
Common Stock Disposition 2017-03-17 1,900 $3.39 1,010,849 No 4 S Direct
Common Stock Disposition 2017-03-21 2,200 $3.40 1,008,649 No 4 S Direct
Common Stock Disposition 2017-03-22 5,000 $3.87 1,003,649 No 4 S Direct
Common Stock Disposition 2017-03-23 5,000 $4.71 998,649 No 4 S Direct
Common Stock Disposition 2017-03-24 3,700 $4.56 994,949 No 4 S Direct
Common Stock Disposition 2017-03-27 5,000 $4.72 989,949 No 4 S Direct
Common Stock Disposition 2017-03-28 5,000 $5.09 984,949 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the holder on January 17, 2017 for the sale of up to 92,000 shares of common stock. Such sales were outside of the holder's investment decision.